Status:

COMPLETED

Cognitive Training for PTSD

Lead Sponsor:

VA Office of Research and Development

Conditions:

Posttraumatic Stress Disorder

Eligibility:

All Genders

21-55 years

Phase:

NA

Brief Summary

Posttraumatic stress disorder (PTSD) is a chronic, disabling condition that occurs in a subgroup of individuals after experiencing traumatic stress, and is common in Veterans seeking mental health tre...

Detailed Description

Posttraumatic Stress Disorder (PTSD) is one of the most prevalent service-related mental health conditions in treatment-seeking Veterans, yet even gold standard interventions are not universally effec...

Eligibility Criteria

Inclusion

  • Eligible participants will be Veterans who:
  • meet primary, current DSM-5 criteria for Posttraumatic Stress Disorder
  • are literate in English
  • intend to remain in the San Diego geographical area for the duration of the study
  • are willing to attend assessment and treatment sessions

Exclusion

  • for the MRI portion, inability to safely complete fMRI session - unsafe metal in body, e.g.:
  • devices such as pacemakers
  • metal fragments in the skin like shrapnel
  • history of metal work or welding
  • history of eye surgery or washes because of metal
  • aortic/aneurysm clips
  • prosthesis
  • bypass surgery/coronary artery clips
  • hearing aids
  • heart-valve replacement
  • intrauterine devices with metal
  • shunts
  • electrodes
  • metal plates/pins/screws
  • neuro or bio-stimulators
  • older tattoos with metal ink
  • piercings the subject is unable or unwilling to remove
  • uncorrectable vision problems
  • claustrophobia
  • inability to lie still on the back for approximately one hour
  • inability to safely fit within the dimensions of the fMRI machine
  • prior neurosurgery
  • pregnancy or current breastfeeding (within 3 months)
  • current IV drug use due to potential cerebrovascular effects
  • or any other conditions that are deemed by Keck Imaging Center staff to contraindicated to safely complete the fMRI scanning
  • a lifetime history of psychotic disorders
  • lifetime history of bipolar disorder
  • severe substance use disorder within the last year
  • other psychiatric conditions that may adversely impact cognition and/or are deemed to require other primary psychological intervention
  • history of any neurological disorder that might be associated with cognitive dysfunction, e.g.:
  • cerebrovascular accident
  • intracranial surgery
  • aneurysm
  • seizure disorder
  • acute suicidality (defined as intent, plan, and/or attempt for severe self-harm within the past 3 months)
  • or current circumstances that present a direct threat to the individual and require more imminent intervention, e.g.:
  • current domestic abuse
  • individuals planning to begin medication changes within the time-frame of the study
  • individuals currently undergoing evidence-based psychotherapy for PTSD
  • individuals planning non-PTSD related psychosocial therapy change within the pre- to post-treatment time frame of the study
  • those with life-threatening or acutely unstable medical conditions

Key Trial Info

Start Date :

June 13 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2023

Estimated Enrollment :

81 Patients enrolled

Trial Details

Trial ID

NCT03316196

Start Date

June 13 2018

End Date

May 31 2023

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VA San Diego Healthcare System, San Diego, CA

San Diego, California, United States, 92161-0002